Biotechnology industry in the US to grow at 5.4% until 2023

reogma|Biotechnology industry in the US to grow at 5.4% until 2023

As of 2018, the US biotechnology industry accounted nearly 30% of the global market ranking first. It was followed by Europe with overall 18% market share and thirdly by China at 14% respectively.

  • Definition / Scope
  • Market Overview
  • Top Market Opportunities
  • Market Trends
  • Industry Challenges
  • Technology Trends
  • Regulatory Trends
  • Other Key Market Trends
  • Market Size and Forecast
  • Market Outlook
  • Distribution Chain Analysis
  • Competitive Landscape
  • Key Market Players
  • Strategic Conclusion
  • References
  • Appendix

Definition / Scope

The term 'biotechnology' means combining different advance technologies with biological systems or organisms themselves and in turn familiarize those technologies across various fields. The applications of biotechnology range from agricultural practice to medical sector.

The technology is important to develop microscopic and chemical tools as most of the tools produced under the scope of biotechnology are limited to a cellular level.

Some of the common types of biotechnology which is practiced in the US and around the world are:

Medical biotechnology: It is the use of living cells or other materials found in cells directed at improving human health. The technology is not only used in finding cures but also getting rid of diseases in advance. The science involves finding efficient ways to improve human health, understanding pathogen and human cell biology.

Other techniques to produce drugs involves study of bacteria, plant and animal cells to come up with effective solutions/products. Some of the common applications of biotechnology in healthcare & medicine sector include, pharmaceuticals & drugs, diagnostic testing, cosmetics and dietary supplements.

Some of the common biotech firms operating in this segment in the US are Johnson & Johnson, Pfizer, Merck, P&G, Abbott among others.

Agriculture biotechnology: The segment focuses on developing genetically modified plants to enable high crop yields and instill characteristics to those plants which allows them to resist stress factors such as whether or pests.

The practice allows scientists to identify a gene that causes it and transplant the gene to another plant so that it gains the same desirable characteristic and becomes more durable.

Some of the common applications produced in the US are: GM plants, animal & livestock medicine, herbicides & pesticides among others. Some of the common US firms operating in this space include, ADM, Cargill, Monsanto, Zoetis, Dow AgroSciences.

Industrial Sector: The application in industrial sector range to a large extent where production of cellular structures to production of biological elements are conducted.

For instance, replacing biological materials with concrete materials in construction industry, beer & wine manufacturing, replacing personal care, beauty & home care products with organic products. Some other applications include production of biofuels (renewable energy) and waste management & disposal.

US firms operating in this segment include, DuPont, Chevron, Renewable Energy Group (REG) and 3M.

reogma|Biotechnology industry in the US to grow at 5.4% until 2023


This report is 15 mins read | Subscribe now to read further.

Access all reports on site for only US$9.99/mo


Leave a Reply

Next Post

Water Technology in India is unorganised offering growth potential

Tue Dec 24 , 2019
As of 2018, the US biotechnology industry accounted nearly 30% of the global market ranking first. It was followed by Europe with overall 18% market share and thirdly by China at 14% respectively. Definition / Scope Market Overview Top Market Opportunities Market Trends Industry Challenges Technology Trends Regulatory Trends Other […]
reogma|Biotechnology industry in the US to grow at 5.4% until 2023reogma|Biotechnology industry in the US to grow at 5.4% until 2023

Tags

Tags

Newsletter Signup

Subscribe to our newsletter below and never miss the latest product or an exclusive offer.